Neurometrix Other Current Liabilities

Neurometrix's other current liabilities stands at $410K as of December 2024. That compares with $880K in the prior-year period — down 52.8% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Neurometrix reported $410K in other current liabilities versus $880K a year earlier — a 52.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $880K in the prior-year period — down 52.8% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Neurometrix's other current liabilities evolved across reporting periods, while the comparison chart places NURO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current liabilities is commonly used to spot outliers. Neurometrix's reading of $410K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.